Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 10 years
- Director since
- 2023
10 years of board service in total across 3 boards, counting each seat separately. Longest: Voyager Therapeutics Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Voyager Therapeutics Inc. June 9, 202670.5%
-
Fulcrum Therapeutics Inc. June 17, 202485.0%
-
Voyager Therapeutics Inc. June 6, 202380.2%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 12, 2024 | Palvella Therapeutics Inc. | Sold back to the company | −1 | $0.01 | $0 |
| Aug 7, 2024 | Palvella Therapeutics Inc. | Open-market purchase | +1 | $1.00 | $1 |
Questions about James A. Geraghty
What boards is James A. Geraghty on?
James A. Geraghty sits on the boards of Fulcrum Therapeutics Inc., Palvella Therapeutics Inc. and Voyager Therapeutics Inc.
How long has James A. Geraghty served on boards?
Our records show at least 10 years of board service across 3 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.